{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:52:19Z","timestamp":1761630739102,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ad.2015.10.004","type":"journal-article","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T02:52:40Z","timestamp":1449197560000},"page":"207-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Despistaje de tuberculosis latente en el paciente con psoriasis moderada grave candidato a terapia sist\u00e9mica y\/o biol\u00f3gica"],"prefix":"10.1016","volume":"107","author":[{"given":"A.","family":"Mart\u00ednez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rodriguez-Granger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ruiz-Villaverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2015.10.004_bib0005","unstructured":"Informe mundial sobre la tuberculosis 2014 [consultado 23 Jul 2015]. Disponible en: http:\/\/www.who.int\/tb\/publications\/global_report\/es\/"},{"key":"10.1016\/j.ad.2015.10.004_bib0010","doi-asserted-by":"crossref","first-page":"e7749","DOI":"10.1371\/journal.pone.0007749","article-title":"Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa","volume":"13","author":"Shanaube","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ad.2015.10.004_bib0015","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1086\/516495","article-title":"Estimation of the annual risk of tuberculosis infection for white men in the United States","volume":"175","author":"Daniel","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ad.2015.10.004_bib0020","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"28","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2015.10.004_bib0025","doi-asserted-by":"crossref","unstructured":"Grupo de trabajo del \u00e1rea TIR de SEPAR. Recomendaciones SEPAR; normativa sobre la prevenci\u00f3n de la tuberculosis. Arch Bronconeumol. 2002;38:441-451.","DOI":"10.1016\/S0300-2896(02)75259-9"},{"key":"10.1016\/j.ad.2015.10.004_bib0030","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1157\/13126836","article-title":"Normativa SEPAR sobre diagn\u00f3stico y tratamiento de la tuberculosis","volume":"44","author":"Ruiz-Manzano","year":"2008","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.ad.2015.10.004_bib0035","first-page":"1376","article-title":"Diagnostic standard and classification of tuberculosis in adults and children","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ad.2015.10.004_bib0040","doi-asserted-by":"crossref","unstructured":"ATS. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-S247.","DOI":"10.1164\/ajrccm.161.supplement_3.ats600"},{"key":"10.1016\/j.ad.2015.10.004_bib0045","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/archinte.161.14.1760","article-title":"The effect of BCG vaccination on tuberculin reactivity and the booster effect among hospital employees","volume":"161","author":"Moreno","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ad.2015.10.004_bib0050","first-page":"1192","article-title":"False-positive tuberculin skin test: What is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J tuber Lung Dis"},{"key":"10.1016\/j.ad.2015.10.004_bib0055","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis","volume":"178","author":"Maharias","year":"1996","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ad.2015.10.004_bib0060","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/iai.63.5.1710-1717.1995","article-title":"Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis","volume":"63","author":"Sorensen","year":"1995","journal-title":"Infect Inmmun"},{"key":"10.1016\/j.ad.2015.10.004_bib0065","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis","volume":"356","author":"Andersen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2015.10.004_bib0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ad.2015.10.004_bib0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/CVI.00364-07","article-title":"Comparison of two commercially available gamma-interferon blood tests for immunodiagnosis of tuberculosis","volume":"15","author":"Dominguez","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.ad.2015.10.004_bib0080","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0962-8479(95)90520-0","article-title":"The typically atypical radiographic presentation of tuberculosis in advanced HIV disease","volume":"76","author":"Daley","year":"1995","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.ad.2015.10.004_bib0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/ajrccm.158.1.9712001","article-title":"Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS","volume":"158","author":"Narita","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ad.2015.10.004_bib0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0001-7310(09)70821-X","article-title":"Consensus document on the evaluation and treatment of moderate-to-severe psoriasis Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology","volume":"100","author":"Puig","year":"2009","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2015.10.004_bib0095","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/jdv.12011","article-title":"Latent tuberculosis infection and active tuberculosis in patients with psoriasis: A study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain BIOBADADERM registry","volume":"27","author":"S\u00e1nchez-Moya","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2015.10.004_bib0100","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0001-7310(09)71257-8","article-title":"Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents","volume":"100","author":"Puig","year":"2009","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2015.10.004_bib0105","unstructured":"Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization; 2015 [consultado 23 Jul 2015]. Disponible en: http:\/\/www.who.int\/tb\/publications\/latent-tuberculosis-infection\/en\/"},{"key":"10.1016\/j.ad.2015.10.004_bib0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ad.2015.10.004_bib0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-\u03b3 release assays for incident active tuberculosis: A systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ad.2015.10.004_bib0120","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/ijd.12522","article-title":"Screening for latent tuberculosis infection in psoriasis and psoriatic arthritis patients in a tuberculosis-endemic country: a comparison of the QuantiFERON\u00ae-TBGold In-Tube test and tuberculin skin test","volume":"53","author":"Duman","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2015.10.004_bib0125","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2340\/00015555-1151","article-title":"Evaluation of an IFN-gamma assay in the diagnosis of latent tuberculosis in patients with psoriasis in a highly endemic setting","volume":"91","author":"De Andrade Lima","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2015.10.004_bib0130","first-page":"553","article-title":"Clinical experience of QuantiFERON(\u00ae)-TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan","volume":"164","author":"Chiu","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.10.004_bib0135","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/bjd.12176","article-title":"Evaluating the use of the interferon-\u03b3 response to Mycobacterium tuberculosis-specific antigens in patients with psoriasis prior to antitumour necrosis factor-\u03b1 therapy: A prospective head-to-head cross-sectional study","volume":"168","author":"Martyn-Simmons","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.10.004_bib0140","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/j.1468-3083.2011.04220.x","article-title":"Clinical applicability of quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: A prospective, observational study","volume":"26","author":"Garcovich","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2015.10.004_bib0145","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bjd.13130","article-title":"Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy","volume":"171","author":"Gisondi","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.10.004_bib0150","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/bjd.13539","article-title":"Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry","volume":"172","author":"Gisondi","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.10.004_bib0155","doi-asserted-by":"crossref","first-page":"381929","DOI":"10.1155\/2012\/381929","article-title":"Immunosuppression adversely affects TST but not IGRAs in patients with psoriasis or inflammatory musculoskeletal diseases","volume":"2012","author":"Tavast","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.ad.2015.10.004_bib0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaad.2010.11.055","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 4. Guidelines of care for the management of psoriasis with traditional systemic agents","volume":"65","author":"Menter","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.ad.2015.10.004_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2009.03389.x","article-title":"European S3-guidelines on the systemic treatment of psoriasis vulgaris","volume":"23","author":"Pathirana","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2015.10.004_bib0170","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/ibd.21605","article-title":"Prednisolone treatment affects the performance of QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection","volume":"17","author":"B\u00e9lard","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ad.2015.10.004_bib0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2012.12.966","article-title":"Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: Results of a nationwide cohort study from Taiwan","volume":"69","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.10.004_bib0180","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/bjd.13355","article-title":"Evidence-based guidelines for laboratory screening for infectious diseases before initiation systemic immunosuppressive agents in patients with autoimmune bullous diseases","volume":"171","author":"Keith","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.10.004_bib0185","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jinf.2014.07.026","article-title":"Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis","volume":"69","author":"Latorre","year":"2014","journal-title":"J Infect"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000173101500455X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000173101500455X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:04:04Z","timestamp":1757552644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000173101500455X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S000173101500455X"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2015.10.004","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Despistaje de tuberculosis latente en el paciente con psoriasis moderada grave candidato a terapia sist\u00e9mica y\/o biol\u00f3gica","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AEDV. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}